Showing all 2 results

Show sidebar
Show 50 100 250 500 All
Plus Semi-Automated Urine Analyzer (CL-50) Amaris Medical
Compare

Plus Semi-Automated Urine Analyzer (CL-50)

The Plus Semi-Automated Urine Analyzer (CL-50) is a portable, semi-automated urine test strip analyzer that uses LED reflectance photometry (at 550nm, 620nm, and 720nm wavelengths) to measure up to 14 urinary parameters for rapid, objective urinalysis in clinical and point-of-care settings . Throughput is up to 120 tests per hour (continuous mode) or 60 tests per hour (single strip) with a test time of 60 seconds .
The analyzer measures 14 parameters: pH, nitrite, specific gravity, blood (hemoglobin), glucose, bilirubin, urobilinogen, ketones, leukocytes, protein, calcium, creatinine, microalbumin, and ascorbic acid, with automatic result correction eliminating interference from pH, specific gravity, and urine color .
The instrument features an LCD display, built-in thermal printer, internal memory storage for 1,000 test results, connectivity options (RS-232, PS/2, parallel port), optional barcode reader, and automatic calibration for strip sensitivity . Compact (240 x 190 x 115mm) and lightweight (1.3 kg), the CL-50 Plus is briefcase-portable, designed for use in physician office labs, mobile health units, rural health posts, pharmacy screening programs, school health initiatives, and hospital laboratory backup applications .
For the primary care physician and clinical laboratory scientist, the CL-50 Plus enables rapid UTI diagnosis (leukocyte, nitrite detection), diabetes screening (glucose, ketones), preeclampsia detection (protein, microalbumin), chronic kidney disease monitoring (microalbumin, creatinine, ACR), liver disease screening (bilirubin, urobilinogen), and hydration/acid-base assessment (pH, specific gravity). For the patient, rapid, objective urinalysis enables early detection of urinary tract infections (preventing pyelonephritis and sepsis), timely diagnosis of diabetes and preeclampsia (reducing maternal-fetal complications), and early identification of chronic kidney disease (preserving renal function), particularly in underserved communities where traditional laboratory access is limited .
Add to wishlist
Read more
Quick view
Plus Semi-Automated Urine Analyzer (CL-500) Amaris Medical
Compare

Plus Semi-Automated Urine Analyzer (CL-500)

The Urine Analyzer Plus Semi-Automated (CL-500) is a high-throughput, semi-automated urine test strip analyzer designed for large-volume clinical laboratories, hospital settings, public health screening programs, and high-volume point-of-care facilities . Using LED reflectance photometry at 550nm, 620nm, and 720nm wavelengths, the analyzer measures up to 14 urinary parameters with a throughput of 550 strips per hour and a test time of 65 seconds .
The analyzer features automatic strip feeding for continuous loading without operator intervention, built-in onboard waste collection, and open system compatibility accepting standard urine test strips. The microprocessor-based system stores 5,000 test results with multilingual support (English, Russian, Spanish, Ukrainian), offers comprehensive connectivity (bidirectional LIS, RS-232, USB, WiFi), and includes a built-in thermal printer .
Measured parameters include leukocytes, ketone, nitrite, protein, glucose, blood, calcium, ascorbic acid, urobilinogen, bilirubin, specific gravity, microalbumin, pH, and creatinine—enabling comprehensive urinalysis for UTI diagnosis, diabetes screening, preeclampsia detection, and chronic kidney disease monitoring .
For the clinical laboratory scientist and public health program manager, the CL-500 Plus enables high-volume UTI diagnosis (550 tests/hour), population-based diabetes screening, proteinuria surveillance in large antenatal services, CKD monitoring for hypertension and diabetes programs, and integrated public health reporting via bidirectional LIS connectivity. For the patient, high-throughput urinalysis enables early detection of urinary tract infections (preventing pyelonephritis and urosepsis), timely diagnosis of diabetes and preeclampsia (reducing complications), and early identification of chronic kidney disease (preserving renal function)—particularly in large-scale screening programs where efficient testing is essential for population health impact .
Add to wishlist
Read more
Quick view